Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$614M |
| 2 |
Apple
AAPL
|
+$443M |
| 3 |
BLD
TopBuild
BLD
|
+$391M |
| 4 |
SPCX
SpaceX
SPCX
|
+$329M |
| 5 |
Penumbra
PEN
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.96B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
SNDK
Sandisk
SNDK
|
+$88M |
| 4 |
Southern Company
SO
|
+$80.6M |
| 5 |
PPL
PPL Corp
PPL
|
+$74.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Industrials | 13.64% |
| 3 | Consumer Discretionary | 9.5% |
| 4 | Healthcare | 7.9% |
| 5 | Financials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Equinor
EQNR
$102B
| – | – |
-8,028
| Closed | -$339K |
|
1702
Ericsson
ERIC
$33.5B
| – | – |
-116,906
| Closed | -$1.32M |
|
1703
Erie Indemnity
ERIE
$13.8B
| – | – |
-799
| Closed | -$201K |
|
1704
Elastic
ESTC
$8.93B
| – | – |
-234,651
| Closed | -$11.7M |
|
1705
Evertec
EVTC
$1.79B
| – | – |
-52,115
| Closed | -$1.47M |
|
1706
East-West Bancorp
EWBC
$17.8B
| – | – |
-36,437
| Closed | -$3.89M |
|
|
EWCZ
1707
DELISTED
European Wax Center
EWCZ
| – | – |
-475,616
| Closed | -$2.75M |
|
|
EXAS
1708
PUT
DELISTED
Exact Sciences
EXAS
| – | – |
-39,600
| Closed | -$4.15M |
|
1709
Exponent
EXPO
$3.34B
| – | – |
-14,158
| Closed | -$924K |
|
1710
Extra Space Storage
EXR
$31B
| – | – |
-8,393
| Closed | -$1.1M |
|
1711
Extreme Networks
EXTR
$3B
| – | – |
-96,622
| Closed | -$1.46M |
|
1712
National Vision
EYE
$1.41B
| – | – |
-138,120
| Closed | -$3.58M |
|
1713
EyePoint Inc
EYPT
$459M
| – | – |
-458,102
| Closed | -$5.9M |
|
1714
First Advantage
FA
$3.59B
| – | – |
-208,568
| Closed | -$2.45M |
|
1715
4D Molecular Therapeutics
FDMT
$875M
| – | – |
-15,529
| Closed | -$145K |
|
|
DMC
1716
Del Monte Corp
DMC
$1.48B
| – | – |
-65,831
| Closed | -$2.65M |
|
1717
Franklin Electric
FELE
$4.6B
| – | – |
-12,886
| Closed | -$1.19M |
|
1718
Ferguson
FERG
$46.9B
| – | – |
-45,618
| Closed | -$10.6M |
|
1719
First Financial Bankshares
FFIN
$4.89B
| – | – |
-278,923
| Closed | -$8.21M |
|
1720
Financial Institutions
FISI
$812M
| – | – |
-23,744
| Closed | -$753K |
|
1721
CALL
Five Below
FIVE
$13.8B
| – | – |
-10,000
| Closed | -$2.25M |
|
1722
FIVE9
FIVN
$2.45B
| – | – |
-76,689
| Closed | -$1.16M |
|
1723
Flowserve
FLS
$10.1B
| – | – |
-11,098
| Closed | -$816K |
|
1724
FMC
FMC
$1.38B
| – | – |
-20,008
| Closed | -$345K |
|
1725
FNB Corp
FNB
$6.6B
| – | – |
-84,258
| Closed | -$1.41M |
|
Similar funds
Michael Gelband's Q2 2026 Portfolio in Review
As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.
- Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
- Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
- Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
- Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
- Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
- Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
- Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.